Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Psychopharmacology"
DOI: 10.1177/02698811211066714
Abstract: Background: Depression is a major mental health issue worldwide, with high rates of chronicity and non-recovery associated with the condition. Existing treatments such as antidepressant medication and psychological treatments have modest effectiveness, suggesting the need… read more here.
Keywords: psilocybin; ecstasy psilocybin; past year; use ... See more keywords